US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Astellas Pharma, Inc.

9.35

+0.14001.52%

Volume:169.54K

Turnover:1.57M

Market Cap:17.41B

PE:125.75

High:9.38

Open:9.22

Low:8.98

Close:9.21

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Astellas Pharma, Inc.

Exchange:

PINK LIMITED

Establishment Date:

1923

Employees:

14754

Office Location:

2-5-1, Nihonbashi-Honcho,Chuo-Ku,Tokyo,Japan

Website:

http://www.astellas.com/en/index.html

Zip Code:

103-8411

Phone:

Fax:

- -

Introduction:

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALPMY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":9.35,"timestamp":1744920000000,"preClose":9.21,"halted":0,"volume":169535,"delay":15,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"Closed Good Friday","change":0.14,"latestTime":"04-17 16:00:00 EDT Delay","open":9.22,"high":9.38,"low":8.98,"amount":1572591.387100002,"amplitude":0.043431,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":9.21,"volumeRatio":0.34287439711953455},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","floatShares":1731101601,"roa":"3.67%","roe":"-3.83%","lyrEps":0.062841,"volumeRatio":0.34287439711953455,"shares":1861787075,"dividePrice":0.506376,"high":9.38,"amplitude":0.043431,"preClose":9.21,"low":8.98,"week52Low":8.37,"pbRate":"1.66","psRate":"1.33","week52High":13.14,"institutionHeld":0,"latestPrice":9.35,"eps":0.074352,"divideRate":0.054158,"volume":169535,"delay":15,"ttmEps":0.074352,"open":9.22,"prevYearClose":9.66,"prevWeekClose":8.88,"prevMonthClose":9.66,"prevQuarterClose":9.66,"fiveDayClose":8.94,"twentyDayClose":9.87,"sixtyDayClose":9.45,"earningDate":1745424000000,"earningTime":"盘后"},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":874641,"yearFounded":1923,"employeeNum":14754,"address":"2-5-1, Nihonbashi-Honcho,Chuo-Ku,Tokyo,Japan","zipCode":"103-8411","officePhone":"81 3 3244 3000"},"stockCompanyDetail":{"websiteUrl":"http://www.astellas.com/en/index.html","stockEarnings":[{"period":"1week","weight":0.0536},{"period":"1month","weight":0.0272},{"period":"3month","weight":0.0336},{"period":"6month","weight":0.0439},{"period":"1year","weight":-0.1101},{"period":"ytd","weight":0.1762}],"description":"Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.","exchange":"PINK LIMITED","name":"Astellas Pharma, Inc.","nameEN":"Astellas Pharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-04","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-01","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722499200000,"name":null,"time":"","dateTimestamp":1722484800000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1683000000000}}}